Key Takeaways
- • Established venture firms captured 91% of capital raised in Q1 2026, up sharply from 74% in 2025, marking the highest concentration in PitchBook's database and signaling a dramatic flight to established brands among limited partners.
- • Emerging managers face a significantly harder fundraising environment, with LPs increasingly demanding longer track records, transparent fee structures, co-investment opportunities, and evidence of actual distributions rather than paper gains.
- • BBG Ventures, led by Nisha Dua and Susan Lyne, closed a $60 million fund in 2024—its largest to date—after navigating a difficult fundraising cycle, demonstrating the capital constraints facing even well-regarded emerging firms focused on underrepresented founder demographics.
- • The concentration trend reflects a fundamental shift in LP behavior: familiarity and proven durability now outweigh thesis-driven diversification, creating a winner-take-most dynamic that pressures smaller and newer firms regardless of investment merit.
Summary
Nisha Dua, venture capitalist and cofounder of BBG Ventures, articulated the sentiment affecting the emerging manager cohort: "It's harder than ever to raise a fund as an emerging manager." The challenge extends beyond simple capital scarcity. LPs are now enforcing significantly higher standards for fund approval, including lengthened fundraising timelines, demands for enhanced fee transparency, expanded co-investment rights, and a shift from valuation gains to actual cash distributions as evidence of manager performance. This disciplinary turn has made the fundraising process more arduous even for experienced teams with established track records.
BBG Ventures exemplifies the pressures facing specialized emerging firms. In 2024, Dua and cofounder Susan Lyne closed the firm's fourth fund at $60 million—their largest vehicle to date—only after what Dua characterized as a difficult fundraising period. BBG, operating under the tagline "Built by Girls," has spent over a decade backing female founders and entrepreneurs from underrepresented backgrounds. The firm's investment thesis centers on the principle that founders with intimate knowledge of a problem are optimally positioned to build software solutions, leading the firm into consumer, health care, and small-business services sectors. Notable portfolio successes include early-stage investments in Spring Health, later valued at $3 billion, and Starface, a skincare company recognized for its pimple patch products. Despite these demonstrated returns, the firm encountered substantial headwinds in fundraising, underscoring how even strong emerging managers face structural capital allocation disadvantages in the current environment.
The concentration trend reflects a fundamental shift in LP decision-making away from thesis-driven diversification and toward what industry participants describe as a "flight to familiarity." Limited partners have historically favored established brands with visible long-term track records and verifiable returns, but this preference has intensified markedly. As fundraising becomes more selective and performance metrics more demanding, the venture ecosystem appears to be entering a winner-take-most phase where capital flows disproportionately to top-tier incumbents, constraining opportunities for emerging managers to build track records and scale operations.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.